New AI system could predict organ damage in cancer patients on immunotherapy
NCT ID NCT07131007
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 26 times
Summary
This study aims to create an early-warning system that predicts organ damage in cancer patients receiving immune checkpoint inhibitor therapy. Researchers will analyze genetic, protein, and metabolic data from 2,000 participants to identify warning signs of side effects in organs like the heart, lungs, and liver. The goal is to help doctors personalize treatment and improve safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fourth Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.